We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUSHA icon
3001
Rush Enterprises Class A
RUSHA
$9.62B
$48K ﹤0.01%
1,589
-8,410
-84% -$249K
TILE icon
3002
Interface
TILE
$2.24B
$48K ﹤0.01%
3,184
+86
+3% +$1.24K
UBX
3003
DELISTED
Unity Biotechnology
UBX
$48K ﹤0.01%
1,627
+1,212
+292% +$42.8K
EVBG
3004
DELISTED
Everbridge, Inc. Common Stock
EVBG
$48K ﹤0.01%
322
+123
+62% +$18.2K
IRNT
3005
DELISTED
IronNet, Inc.
IRNT
$48K ﹤0.01%
+2,781
New +$40.9K
ALF
3006
DELISTED
ALFI Inc
ALF
$48K ﹤0.01%
7,266
-1,164
-14% -$10.8K
NBEV
3007
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$48K ﹤0.01%
34,723
-11,505
-25% -$20.9K
ADAP
3008
DELISTED
Adaptimmune Therapeutics
ADAP
$47K ﹤0.01%
9,079
+4,839
+114% +$21.7K
ADPT icon
3009
Adaptive Biotechnologies
ADPT
$3.89B
$47K ﹤0.01%
1,374
-7,734
-85% -$280K
ALX
3010
Alexander's
ALX
$1.4B
$47K ﹤0.01%
181
+91
+101% +$24.3K
BBDC icon
3011
Barings BDC
BBDC
$987M
$47K ﹤0.01%
4,242
+3,874
+1,053% +$41.8K
BJRI icon
3012
BJ's Restaurants
BJRI
$1.42B
$47K ﹤0.01%
1,103
+552
+100% +$23.2K
EEIQ icon
3013
EpicQuest Education Group
EEIQ
$4.08M
$47K ﹤0.01%
+717
New +$52.8K
TDAY
3014
USA Today Co
TDAY
$1B
$47K ﹤0.01%
7,056
+2,306
+49% +$13.6K
DMRA
3015
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
$47K ﹤0.01%
525
+210
+67% +$22.5K
PAR icon
3016
PAR Technology
PAR
$770M
$47K ﹤0.01%
772
-1,597
-67% -$102K
PJT icon
3017
PJT Partners
PJT
$4.57B
$47K ﹤0.01%
600
-4,014
-87% -$308K
RBLX icon
3018
Roblox
RBLX
$27.1B
$47K ﹤0.01%
621
-6,979
-92% -$573K
RETL icon
3019
Direxion Daily Retail Bull 3X ETF
RETL
$27.8M
$47K ﹤0.01%
1,265
-9,625
-88% -$427K
RKT icon
3020
Rocket Companies
RKT
$42.6B
$47K ﹤0.01%
2,885
+1,277
+79% +$22.3K
RXT icon
3021
Rackspace Technology
RXT
$1.1B
$47K ﹤0.01%
3,273
-555
-14% -$8.92K
SLDB icon
3022
Solid Biosciences
SLDB
$974M
$47K ﹤0.01%
1,320
+748
+131% +$31.8K
BRG
3023
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$47K ﹤0.01%
3,711
-100
-3% -$1.16K
NPTN
3024
DELISTED
NEOPHOTONICS CORP
NPTN
$47K ﹤0.01%
5,491
-10,908
-67% -$99.4K
CCOI icon
3025
Cogent Communications
CCOI
$530M
$46K ﹤0.01%
646
-2,972
-82% -$221K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.